arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

COMPUGEN LTD

CGEN
$1.92 ▼ -0.12 (-5.65%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
18 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
92
Health
Excellent
Bullish
auto_awesome

Analytical Summary

COMPUGEN LTD shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $179.4M
Dividend Yield —
Revenue Growth 161.1% ↗
Op. Margin 43.1% ↗
ROIC 30.4% ↗
FCF / Share $0.34 ↘
Trailing P/E 5.1x
Price / Book 1.8x
FCF Yield 17.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.76M
↑ +161.1% —
Net Income Profit after all expenses
$35.34M
↑ +348.4% —
Operating Margin Operating profit as % of sales
43.1%
↑ +180.6% 95th
FCF / Share Free cash flow per share
$0.34
↓ -39.3% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
97
Returns
94
Financial Health
99
Cash Quality ↑
60

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 18 quarters